Mar 29, 2023 / 02:30PM GMT
Gage Greeno - Ascent Conference - Moderator
Good morning, everyone, and welcome back to the Investor Summit March event. Presenting now is Jim Martin, Co-CEO and CFO of Cocrystal Pharma. Jim, I'm going to let you go ahead and get started.
Jim Martin - Cocrystal Pharma, Inc. - Interim Co-CEO & CFO
All right, great. Thank you everyone for your interest in Cocrystal. Thank you, Investor Summit for having us. I'll get started right away. So Cocrystal is a therapeutic antiviral company. I want to make that clear, we are not a vaccine company. We actually target the virus once it enters the body. And as I'll get into, we target the replication of these viruses. We have very advanced programs in clinical stage. We also have very validated mechanisms of action and our proprietary drug discovery platform, which was derived from our Nobel Laureate founder. It has been the core of our programs.
Investor highlights are that we target multibillion global markets for the treatment of both acute and pandemic diseases. These are compounds that are derived off of
Cocrystal Pharma Inc Virtual Investor Summit Transcript
Mar 02, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers